The use of Ivermectin is being unreasonably restricted in SA by the necessity to make a section 25 application to the SA Health Products Regulatory Authority  (SAHPRA) every time a doctor wants to prescribe it to a patient. 

With Covid-19 it has been shown that it is vital to treat the patient as soon as symptoms are experienced. The delay, administrative burden and cost of having to fill in and submit section 25 applications means Ivermectin is not being widely used here and many people are dying or being unnecessarily hospitalised. ..

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.